Product Information

POTASSIUM CITRATE ER 5 MEQ TAB is a generic product labeled by Strides Pharma Inc., priced at $0.1147 per EA under NDC 42543040601. Its NADAC has been published 478 times since Sep 27, 2017.

FDA first approved this application on Sep 11, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CITRATE ER 5 MEQ TAB

POTASSIUM CITRATE
$0.1147per EA

Strength

5 meq/1

NDC

42543040601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

POTASSIUM CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206813

FDA Approved

9/11/2017

TE Code

AB

On Market Since

11/1/2017

Pharmacological Classes

Acidifying Activity
Anti-coagulant
Calcium Chelating Activity
Calculi Dissolution Agent
Decreased Coagulation Factor Activity

Price Statistics

The NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has been published 478 times since Sep 27, 2017, and over the history we have for it it has declined 87.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1147 per EA
All-time high$0.9672 (Nov 15, 2017)
All-time low$0.1064 (May 22, 2024)
52-week high$0.1419
52-week low$0.1145
Median price$0.4508
Average price$0.4234
Largest weekly change+79.1% (Jan 18, 2023)
Weeks tracked478
Tracking sinceSep 27, 2017

Price History

1W

+0.1%

1M

+0.1%

3M

-14.1%

6M

-11.0%

1Y

-5.9%

3Y

-60.3%

5Y

-81.2%

All

-87.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the POTASSIUM CITRATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of POTASSIUM CITRATE ER 5 MEQ TAB?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 5 MEQ TAB, manufactured by Strides Pharma Inc., is $0.1147 per EA (NDC 42543040601), effective Nov 18, 2026.

How has the price of POTASSIUM CITRATE ER 5 MEQ TAB changed over time?

Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has declined 87.4%. It has been tracked across 478 weekly CMS publications since Sep 27, 2017.

What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 5 MEQ TAB?

Since Sep 27, 2017, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has ranged from a low of $0.1064 (May 22, 2024) to a high of $0.9672 (Nov 15, 2017), with a median of $0.4508 per EA.

Are there cheaper alternatives to POTASSIUM CITRATE ER 5 MEQ TAB?

No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CITRATE ER 5 MEQ TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures POTASSIUM CITRATE ER 5 MEQ TAB?

POTASSIUM CITRATE ER 5 MEQ TAB (NDC 42543040601) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.